Access our full collection of sustainable healthcare resources, such as toolkits, case studies, publications and more. You can also add new resources to the library.
ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular–kidney–metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus…
Frances Mortimer, CSH's Medical Director, responds to BMJ article, "Environmental Lessons Learned and Applied (ELLA): a new framework for identifying, prioritising and implementing decarbonisation…
AbstractThe burden of chronic kidney disease (CKD) and its risk factors are projected to rise in parallel with the rapidly ageing global population. By 2050, the prevalence of CKD category G3–G5 may…
Published date
July 2024
•
by
Chesnaye, NC., Ortiz, A., Zoccali, C., Stel, VS., Jager, KJ.
CSH's Nursing & Midwifery Susnet January Event.About the speakerDavid is a registered nurse, specialised in emergency and critical care and tropical medicine, and holds a master's degree in global…
CSH Kidney Care Sustainability Network January Event.About the speaker: Dr Tamara Glavinovic – Nephrologist, University of OttawaDr Glavinovic is a nephrologist with a clinical focus on reproductive…
Despite the availability of kidney replacement therapy (KRT), chronic kidney disease (CKD) is among the fastest increasing global causes of premature death. Longer life expectancy and population aging…
The guide lists 13 high impact and practical clinical recommendations for decarbonising elective hip replacement surgery, covering every step of the patient pathway from community care and referral…
Diabetes is the most common cause of chronic kidney disease (CKD), a condition found in 850 million persons and projected to become the fifth global cause of death by 2040. Research is needed that…
This resource from Getting it Right First Time (GIRFT) is part of the‘greener’ pathwaysseries. It highlightsthesteps that can be taken by trusts to decarbonise theelectivehip replacement pathway,…
